Literature DB >> 18784903

Subfoveal choroidal neovascularization in a patient with Fabry's disease.

Andrea Sodi1, Alessandro Bini, Renzo Mignani, Barbara Minuti, Ugo Menchini.   

Abstract

INTRODUCTION: Fabry disease (FD) is an X-linked, inherited disorder caused by a deficiency of the enzyme alpha-galactosidase A, with progressive accumulation of glycosphingolipids within several tissues and organs, including the eye. Ophthalmological manifestations include conjunctival vessel tortuosity, cornea verticillata, lens opacity, and retinochoroidal vessel abnormalities. REPORT: In FD, the presence of macular choroidal neovascularization (CNV) has never been previously described. DISCUSSION: We report the case of a FD patient who developed an early-onset CNV, when he was still in his 40s.

Entities:  

Mesh:

Year:  2008        PMID: 18784903     DOI: 10.1007/s10792-008-9252-0

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  4 in total

Review 1.  Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies.

Authors:  Jayakrishna Ambati; Balamurali K Ambati; Sonia H Yoo; Sean Ianchulev; Anthony P Adamis
Journal:  Surv Ophthalmol       Date:  2003 May-Jun       Impact factor: 6.048

Review 2.  Vascular complications of Fabry disease: enzyme replacement and other therapies.

Authors:  D A Hughes; A B Mehta
Journal:  Acta Paediatr Suppl       Date:  2005-03

3.  Ocular blood flow velocity in age-related macular degeneration.

Authors:  E Friedman; S Krupsky; A M Lane; S S Oak; E S Friedman; K Egan; E S Gragoudas
Journal:  Ophthalmology       Date:  1995-04       Impact factor: 12.079

4.  An association study of inflammatory cytokine gene polymorphisms in Fabry disease.

Authors:  Rachael Safyan; Catharina Whybra; Michael Beck; Deborah Elstein; Gheona Altarescu
Journal:  Eur Cytokine Netw       Date:  2006-12       Impact factor: 2.737

  4 in total
  2 in total

1.  Longitudinal study on ocular manifestations in a cohort of patients with Fabry disease.

Authors:  Langis Michaud
Journal:  PLoS One       Date:  2019-06-27       Impact factor: 3.240

2.  Rats deficient in α-galactosidase A develop ocular manifestations of Fabry disease.

Authors:  James J Miller; Kazuhiro Aoki; Christopher A Reid; Michael Tiemeyer; Nancy M Dahms; Iris S Kassem
Journal:  Sci Rep       Date:  2019-06-28       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.